Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2017 16:05 ET | Source: Endologix

Endologix Reports Results for the Fourth Quarter and Full Year 2016

IRVINE, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
February 14, 2017 16:01 ET | Source: Endologix

Endologix Completes Patient Enrollment in the Ovation® LUCY Study

IRVINE, Calif., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
February 07, 2017 09:00 ET | Source: Endologix

Endologix to Report Fourth Quarter and Full Year 2016 Financial Results on February 22, 2017

IRVINE, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the release...
February 06, 2017 09:00 ET | Source: Endologix

Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board

John McDermott to Continue as Chief Executive Officer IRVINE, Calif., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic...
February 03, 2017 16:05 ET | Source: Endologix

Endologix to Present at Leerink Partners 6th Annual Global Healthcare Conference

IRVINE, Calif., Feb. 03, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Vaseem Mahboob, Chief...
January 25, 2017 12:00 ET | Source: Endologix

Endologix Announces Reinstatement of CE Mark for AFX® and AFX2 Endovascular AAA Systems

IRVINE, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced that it received notice from...
January 25, 2017 09:00 ET | Source: Endologix

Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium

IRVINE, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive...
January 17, 2017 10:28 ET | Source: Endologix

Endologix Resumes Shipments of All Sizes of AFX®2 Endovascular AAA Systems

IRVINE, Calif., Jan. 17, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced that the company has resumed...
January 03, 2017 16:01 ET | Source: Endologix

Endologix to Present at the 35th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
December 30, 2016 08:00 ET | Source: Endologix

Endologix Provides Physicians with Updated Information about the AFX® Endovascular AAA System

IRVINE, Calif., Dec. 30, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today issued a letter to physicians with...